Production (Stage)
Pasithea Therapeutics Corp.
KTTA
$0.69
$0.00070.10%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -13.61M | -13.90M | -15.78M | -16.39M | -16.28M |
| Total Depreciation and Amortization | 648.60K | 649.20K | 649.20K | 649.20K | 649.20K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 561.30K | 851.60K | 262.60K | 710.20K | 320.20K |
| Change in Net Operating Assets | -260.80K | -1.52M | -522.50K | 108.50K | 954.90K |
| Cash from Operations | -12.66M | -13.92M | -15.39M | -14.92M | -14.36M |
| Capital Expenditure | -- | -- | 0.00 | 22.70K | 19.60K |
| Sale of Property, Plant, and Equipment | -- | -- | 54.50K | 82.00K | 109.50K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 594.40K | 0.00 | 323.80K |
| Cash from Investing | -- | -- | 648.90K | 104.70K | 452.90K |
| Total Debt Issued | -- | -- | 0.00 | 0.00 | 0.00 |
| Total Debt Repaid | -- | -- | 0.00 | -133.30K | -264.10K |
| Issuance of Common Stock | 1.65M | 300.00 | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | 0.00 | -3.73M | -3.73M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 4.34M | 4.52M | 4.54M | -- | -4.20K |
| Cash from Financing | 5.99M | 4.52M | 4.54M | -3.86M | -3.99M |
| Foreign Exchange rate Adjustments | -1.90K | -2.50K | -27.50K | -4.70K | -2.10K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -6.67M | -9.41M | -10.22M | -18.68M | -17.90M |